# A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

> **NCT04565574** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** E7090
- **DRUG:** Rabeprazole 20 mg
- **DRUG:** Rifampin 600 mg

## Key facts

- **NCT ID:** NCT04565574
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-16
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565574, "A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04565574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*